Conversation
Replying to
This letter was written by David Clark, senior vice president Health and Medical Sciences of Elsevier ltd.
1
1
3
Replying to
A face-saving non-answer, given the absurd fact that participants could be improved and disabled simultaneously
2
3
Replying to


